BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:16 PM
 | 
Nov 19, 2007
 |  BC Extra  |  Company News

FDA approves Nexavar for HCC

FDA approved an sNDA from Bayer (FSE:BAY) and Onyx (ONXX) for Nexavar sorafenib...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >